Tezepelumab for allergic bronchopulmonary aspergillosis
Treatments studied
Part of Immune system & allergy, Infections, Lungs & breathing clinical trials.
This study looks at whether tezepelumab, a biologic medication, can help people with allergic bronchopulmonary aspergillosis (ABPA) and severe asthma. It aims to reduce asthma attacks and improve breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with allergic bronchopulmonary aspergillosis, which is confirmed by a skin or blood test (or a positive test for specific antibodies).
- You have had severe asthma for at least 12 months and take high-dose inhaled steroids plus another controller medicine for at least 3 months.
- You have had at least 2 asthma attacks in the past year that required oral, injected, or IV steroids.
- You weigh more than 40 kg (about 88 lbs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if biologic drugs are safe and effective for people with allergic bronchopulmonary aspergillosis (ABPA) who also have severe asthma. It may help if you've had an asthma attack in the past year.
This study tests whether benralizumab, a biologic medicine, works well in real-world settings for people with severe asthma caused by an allergic reaction to a common mold called Aspergillus. You may qualify if you have hard-to-control asthma despite strong medications and recent asthma flare-ups.
This study looks at how well a new injectable medicine called depemokimab works for people who have both allergic bronchopulmonary aspergillosis (ABPA) and severe eosinophilic asthma. It aims to see if this medication helps control symptoms and reduce the need for steroids.
This trial tests a procedure that uses a bronchoscope to clean mucus from the airways and then spray the antifungal drug amphotericin B directly into the lungs. It may help people whose ABPA is active and not improving with standard treatments.
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
This trial tests if a drug called Tezepelumab can help adults with asthma who visit the emergency room. It aims to reduce severe asthma attacks and improve breathing control.
Hear when a new Allergic Bronchopulmonary Aspergillosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.